Trial intelligence / Profile preview

Exosomes vs Ozone Therapy for ED Post-RARP

NCT07707505Not yet recruiting

Sponsor
Istanbul Medipol University
Start
Aug 2026
Primary completion
Jan 2027
Countries
1
01

Overview

Randomised, open-label trial of medical ozonated water in erectile dysfunction (ED) (3 arms), sponsored by Istanbul Medipol University. Primary endpoint: International Index of Erectile Function at 6 months. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

medical ozonated water
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT07707505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07707505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call